Back to MW MARSHALL WACE, LLP

ABTABT
Showing 7 of 27 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ABBOTT LABORATORIES

MARSHALL WACE, LLP holds 5.5M shares of ABT (ABBOTT LABORATORIES), worth $502.9M as of 2026-Q2. The position was increased (+175.6% shares). ABT represents 0.4% of MARSHALL WACE, LLP's portfolio.

Current Value

$502.9M

Current Shares

5.5M

Total Value Change

+$488.9M

Total Shares Change

+5.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.5M
+175.6%
$502.9M0.4%$90.10
60
2026-Q1
Increased
2M
+3338.3%
$206.5M0.2%$101.31
59
2025-Q4
New
58,487
-
$7.3M0.0%$123.00
38
2025-Q2
Exited
0
-100.0%
$00.0%$132.34
0
2025-Q1
New
156,935
-
$20.8M0.0%$128.48
39
2024-Q4
Exited
0
-100.0%
$00.0%$108.98
0
2024-Q3
Decreased
123,227
-43.0%
$14M0.0%$109.33
0

Other major holders of ABT: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used